Synthon leverages its vertically integrated business model over various locations.
Synthon's headquarters are located in Nijmegen, The Netherlands. This location also houses research and development facilities for both generic and biotechnological pharmaceuticals.
We have globally oriented API and drug product manufacturing facilities in the Czech Republic, Argentina and Spain, while our US facility is dedicated to GMP biological manufacturing. Our facilities in Mexico and Chile manufacture and package products for the local markets. In addition, our recently opened multi-purpose drug product site in Chile will be compliant with local and European GMP standards and contains state-of-the-art facilities varying from development to large-scale production of tablets, capsules and pre-filled syringes.
Further, Synthon has dedicated business development offices in Russia, Australia and South Korea. We intend to continue expanding globally and are continually looking to find new partners for our products in all major markets.